Frank Wu

Person

Nanjing, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Method for treating a cancer mediated by abnormality of multi-kinases
- Patent number 11,718,620
- Issue date Aug 8, 2023
- TransThera Sciences (Nanjing), Inc.
- Frank Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Halo-allylamine SSAO/VAP-1 inhibitor and use thereof
- Patent number 11,649,233
- Issue date May 16, 2023
- NANJING TRANSTHERA BIOSCIENCES CO., LTD.
- Frank Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PDE9 inhibitor and use thereof
- Patent number 11,434,248
- Issue date Sep 6, 2022
- Nanjing TransThera Biosciences Co. Ltd.
- Frank Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indoleamine 2,3-dioxygenase inhibitor and application
- Patent number 11,046,679
- Issue date Jun 29, 2021
- Nanjing TransThera Biosciences Co. Ltd.
- Frank Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PDE9 inhibitor and use thereof
- Patent number 10,889,591
- Issue date Jan 12, 2021
- Nanjing TransThera Biosciences Co. Ltd.
- Frank Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multi-kinase inhibitor compound, and crystal form and use thereof
- Patent number 10,889,586
- Issue date Jan 12, 2021
- Nanjing TransThera Biosciences Co. Ltd.
- Frank Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of fibroblast growth factor receptor and use thereof
- Patent number 10,744,139
- Issue date Aug 18, 2020
- Nanjing TransThera Biosciences Co. Ltd.
- Frank Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multi-kinase inhibitor compound, and crystal form and use thereof
- Patent number 10,208,042
- Issue date Feb 19, 2019
- Nanjing TransThera Biosciences Co. Ltd.
- Frank Wu
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF
- Publication number 20250152584
- Publication date May 15, 2025
- TransThera Sciences (Nanjing), Inc.
- Lin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINED USE OF MULTIKINASE INHIBITOR
- Publication number 20250082650
- Publication date Mar 13, 2025
- TRANSTHERA SCIENCES (NANJING), INC.
- Peng PENG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NLRP3 INFLAMMASOME INHIBITOR AND APPLICATION THEREOF
- Publication number 20240294542
- Publication date Sep 5, 2024
- TransThera Sciences (Nanjing), Inc.
- Lin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTAL FORM OF FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITOR AND PRE...
- Publication number 20240043408
- Publication date Feb 8, 2024
- TRANSTHERA SCIENCES (NANJING), INC.
- Frank WU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL USE OF MULTIKINASE INHIBITOR
- Publication number 20230129164
- Publication date Apr 27, 2023
- TRANSTHERA SCIENCES (NANJING), INC.
- Peng Peng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC DERIVATIVE AND USE THEREOF
- Publication number 20220298146
- Publication date Sep 22, 2022
- TRANSTHERA SCIENCES (NANJING), INC.
- Frank WU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USES OF PHOSPHODIESTERASE INHIBITORS
- Publication number 20220160696
- Publication date May 26, 2022
- TRANSTHERA SCIENCES (NANJING), INC.
- Zejuan SHENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PDE9 INHIBITOR AND USE THEREOF
- Publication number 20220089593
- Publication date Mar 24, 2022
- TRANSTHERA SCIENCES (NANJING), INC.
- Frank Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HALOALLYLAMINE COMPOUNDS AND APPLICATION THEREOF
- Publication number 20220081439
- Publication date Mar 17, 2022
- TransThera Sciences (Nanjing), Inc
- Zhonghui WAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL QUINOLINE DERIVATIVE INHIBITOR
- Publication number 20220073496
- Publication date Mar 10, 2022
- Nanjing Transthera Biosciences Co., Ltd.
- Frank Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TAM FAMILY KINASE /AND CSF1R KINASE INHIBITOR AND USE THEREOF
- Publication number 20210177828
- Publication date Jun 17, 2021
- Frank Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTI-KINASE INHIBITOR COMPOUND, AND CRYSTAL FORM AND USE THEREOF
- Publication number 20210130354
- Publication date May 6, 2021
- Nanjing TransThera Biosciences Co. Ltd.
- Frank Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PDE9 INHIBITOR AND USE THEREOF
- Publication number 20210130366
- Publication date May 6, 2021
- Nanjing TransThera Biosciences Co. Ltd.
- Frank Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HALO-ALLYLAMINE SSAO/VAP-1 INHIBITOR AND USE THEREOF
- Publication number 20210070750
- Publication date Mar 11, 2021
- Frank Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PEPTIDYLARGININE DEIMINASE INHIBITOR AND USE THEREOF
- Publication number 20200407370
- Publication date Dec 31, 2020
- Nanjing Transthera Biosciences Co., Ltd.
- Frank Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DEUTERATED INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR AND APPLICATION TH...
- Publication number 20200361919
- Publication date Nov 19, 2020
- Frank Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR AND APPLICATION
- Publication number 20200181131
- Publication date Jun 11, 2020
- Nanjing TransThera Biosciences Co. Ltd.
- Frank WU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PDE9 INHIBITOR AND USE THEREOF
- Publication number 20200115384
- Publication date Apr 16, 2020
- Nanjing TransThera Biosciences Co. Ltd.
- Frank Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR AND USE THEREOF
- Publication number 20200108070
- Publication date Apr 9, 2020
- Nanjing TransThera Biosciences Co. Ltd.
- Frank Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR AND USE THEREOF
- Publication number 20190209564
- Publication date Jul 11, 2019
- Nanjing TransThera Biosciences Co. Ltd.
- Frank Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTI-KINASE INHIBITOR COMPOUND, AND CRYSTAL FORM AND USE THEREOF
- Publication number 20190152972
- Publication date May 23, 2019
- Nanjing TransThera Biosciences Co. Ltd.
- Frank Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTI-KINASE INHIBITOR COMPOUND, AND CRYSTAL FORM AND USE THEREOF
- Publication number 20190040064
- Publication date Feb 7, 2019
- Nanjing TransThera Biosciences Co. Ltd.
- Frank Wu
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Method for treating a cancer mediated by abnormality of multi-kinases

Halo-allylamine SSAO/VAP-1 inhibitor and use thereof

PDE9 inhibitor and use thereof

Indoleamine 2,3-dioxygenase inhibitor and application

PDE9 inhibitor and use thereof

Multi-kinase inhibitor compound, and crystal form and use thereof

Inhibitors of fibroblast growth factor receptor and use thereof

Multi-kinase inhibitor compound, and crystal form and use thereof

Patents Applicationslast 30 patents

NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF

COMBINED USE OF MULTIKINASE INHIBITOR

NLRP3 INFLAMMASOME INHIBITOR AND APPLICATION THEREOF

CRYSTAL FORM OF FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITOR AND PRE...

NOVEL USE OF MULTIKINASE INHIBITOR

HETEROCYCLIC DERIVATIVE AND USE THEREOF

USES OF PHOSPHODIESTERASE INHIBITORS

PDE9 INHIBITOR AND USE THEREOF

HALOALLYLAMINE COMPOUNDS AND APPLICATION THEREOF

NOVEL QUINOLINE DERIVATIVE INHIBITOR

TAM FAMILY KINASE /AND CSF1R KINASE INHIBITOR AND USE THEREOF

MULTI-KINASE INHIBITOR COMPOUND, AND CRYSTAL FORM AND USE THEREOF

PDE9 INHIBITOR AND USE THEREOF

HALO-ALLYLAMINE SSAO/VAP-1 INHIBITOR AND USE THEREOF

PEPTIDYLARGININE DEIMINASE INHIBITOR AND USE THEREOF

DEUTERATED INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR AND APPLICATION TH...

INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR AND APPLICATION

PDE9 INHIBITOR AND USE THEREOF

INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR AND USE THEREOF

INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR AND USE THEREOF

MULTI-KINASE INHIBITOR COMPOUND, AND CRYSTAL FORM AND USE THEREOF

MULTI-KINASE INHIBITOR COMPOUND, AND CRYSTAL FORM AND USE THEREOF